Alerta

Devices, systems and methods for blood glucose monitoring

Resumen de: CN120225115A

Devices, systems, and methods for blood glucose monitoring are disclosed. The apparatus comprises: a light emitter configured to emit a light signal; a light receiver configured to receive a reflected light signal; a controller configured to be operatively connected with the light emitter and the light receiver; and a housing. The light signals comprise a first light signal having a first wavelength of about 940 nm, a second light signal having a second wavelength of about 1350 nm, and/or a third light signal having a third wavelength of about 1500 nm, and wherein the controller comprises an operating module and further comprises or is operatively connected to a data processing system, the data processing system includes a machine learning module that analyzes the data signal to generate output data. The devices, systems, and methods are non-invasive and monitor blood glucose levels in real time with high accuracy.

Memory alloy pump and insulin pump system thereof

Resumen de: CN120204514A

The invention relates to the technical field of medical instruments, in particular to a memory alloy pump and an insulin pump system thereof. The memory alloy pump comprises an upper shell, a lower shell, a memory alloy wire and a power supply; according to the principle that the length of the memory alloy wire is shortened when the memory alloy wire is electrified, power for pushing liquid medicine downwards is provided for the memory alloy pump, and the memory alloy pump is small in size, simple in structure and convenient to carry. The insulin pump system comprises a liquid storage structure, a memory alloy pump, an infusion structure and a micro-processing unit; the micro-processing unit comprises a calculation subunit and a control subunit, the calculation subunit can calculate the power-on time of the memory alloy pump according to input human body blood sugar data and send the power-on time to the control subunit, and the control subunit controls the pump to be powered on according to the power-on time. The purpose of automatically and quantitatively injecting insulin according to the requirement of a patient for insulin is achieved, and the problem that an existing insulin pump cannot automatically inject insulin according to the blood sugar content of a human body is solved.

Insulin pen with voice prompt function and tail device

Resumen de: CN223026472U

The insulin pen tail device comprises an outer support, a sliding support and a voice prompt device, the outer support comprises a barrel with an upper opening and a lower opening, the sliding support is installed on the inner side of the barrel in a sliding mode, the upper portion of the sliding support extends out of the upper end face of the barrel, the sliding support is of an H-shaped structure, and the voice prompt device is arranged on the sliding support. A lower assembly space is formed on the lower side, and an upper assembly space is formed on the upper side; the voice prompt device is installed in the upper assembling space, and at least two transversely-arranged adjusting screws are arranged on the side face of the lower assembling space. The insulin pen clamp has the advantages that insulin pens of different sizes can be clamped for voice broadcast, the use cost is reduced, and the like.

METHODS, SYSTEMS, AND DEVICES FOR CONTINUOUS ANALYTE MONITORING

Resumen de: WO2025134124A1

Embodiments of the disclosure generally relates to systems and methods for real time continuous monitoring of glucose. More specifically, the embodiments of the disclosure relate to a device for continuous glucose monitoring (COM), that includes subcutaneous electrochemical sensor, electronics, and algorithms to improve ease of manufacture, use, and more importantly, the welfare of people with diabetes.

SYSTEMS AND METHODS FOR SELECTIVELY ENABLING AND/OR DISABLING FUNCTIONALITY AND/OR SETTINGS IN A SOFTWARE UPDATE IN AN INSULIN PUMP SYSTEM

Resumen de: WO2025137110A1

Systems and methods are provided for sending a software update to an insulin pump and/or user device used with the insulin pump and selectively enabling and disabling certain functionality (e g., operations, tasks, functions, and/or features) enabled by the software update and/or settings adjusted by the software update. The software update may be in the form of a software package that is sent from a remote device to all insulin pumps or user devices on an insulin pump network. While all devices may receive the same software update it may be desirable to restrict certain functionality and/or settings for some insulin pumps and/or user devices. The insulin pump, user device associated with the insulin pump, and/or remote device in communication with the user device, may determine whether the functionality in the software update should be disabled or otherwise not enabled for a certain insulin pump and/or user device.

METHOD AND APPARATUS FOR PROVIDING GLYCEMIC CONTROL

Resumen de: US2025210156A1

Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.

SECURE BROADCAST MESSAGING IN SUPPORT OF GLUCOSE MONITORING

Resumen de: AU2023401746A1

Techniques for performing application-layer security and communication over primary invitation channels arc disclosed. In certain embodiments, analyte data is obtained from an analyte sensor electrically coupled to a sensor electronics module of an analyte sensor system. A secret key is established with a display device over one or more primary invitation channels. The analyte data is encrypted using the secret key. The encrypted analyte data is broadcast over the one or more primary invitation channels.

PHOTOACOUSTIC DIAGNOSIS DEVICE

Resumen de: US2025204815A1

The present disclosure discloses a photoacoustic diagnostic device. More specifically, the present invention relates to a photoacoustic diagnostic device that detects ultrasound waves generated by irradiating a biological surface with a laser to noninvasively determine blood sugar concentration, or the like in a biological body. According to an embodiment of the present invention, the photoacoustic diagnostic device is equipped with a membrane element manufactured by a micro electro mechanical system (MEMS) process, and instead of mounting an expensive FFT, or the like on a transducer for receiving an ultrasound wave signal radiated from a subject and detecting a resonance peak or using a spectrum analyzer, by detecting multiple resonance peaks through multiple transducers with different resonance frequencies and combining the resonance peaks to perform analysis on blood sugar, or the like, it is possible to provide analysis results with high accuracy that are easy to implement and low cost.

MIXED CONDUCTING, INTRINSICALLY STRETCHABLE ENZYME MEMBRANES AND METHODS OF FABRICATION

Resumen de: US2025204814A1

A stretchable, conducting, and redox-active hydrogel with an interpenetrating double-network structure is provided. This structure is formed by infiltrating a brittle pure-gel conducting hydrogel with a stretchable hydrogel. Ferrocene derivatives are immobilized on the chains of the stretchable hydrogel through covalent bonds, and glucose oxidases are crosslinked to the stretchable hydrogel using a room-temperature crosslinker.

SYSTEMS AND METHODS FOR MANAGING CHRONIC DISEASE USING ANALYTE AND PATIENT DATA

Resumen de: US2025204813A1

Devices, systems, and methods herein relate to managing a chronic condition such as diabetes. These systems and methods may obtain patient data from a plurality of devices, integrate the data for analysis of trends that may be presented to the patient and/or health care professional along with an actionable suggestion. In some variations, a method may include the steps of receiving analyte data generated by an analyte measurement device and patient data generated by a patient measurement device. One or more data trends may be generated by analyzing the analyte data against the patient data using a computing device. The device settings of one or more of the analyte measurement device and the computing device may be modified in response to one or more of the data trends.

INITIAL TOTAL DAILY INSULIN SETTING FOR USER ONBOARDING

Resumen de: US2025205427A1

Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.

APPARATUS FOR MONITORING GLUCOSE AND METHOD THEREOF

Resumen de: US2025204816A1

An apparatus for monitoring glucose according to an embodiment of the present invention includes an input unit that obtains first biometric information including a plurality of data points measuring glucose-related information of a subject; a noise removal unit that removes noise information included in the first biometric information; a preprocessing unit that preprocesses the first biometric information from which the noise information is removed to generate second biometric information having a lower sampling rate than the first biometric information; a compensation unit that generates compensation data based on the second biometric information and generates a calibration algorithm based on the compensation data; and a glucose level acquisition unit that acquires a glucose level related to the second biometric information by reflecting the calibration algorithm and a set time delay.

ANALYTE SENSORS AND SENSING METHODS FEATURING DUAL DETECTION OF GLUCOSE AND KETONES

Resumen de: EP4574038A2

Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.

DISPLAYS FOR A MEDICAL DEVICE

Resumen de: EP4576110A2

Embodiments described herein relate to a glucose monitoring system having a glucose sensor positioned in contact with interstitial fluid in a body of a user. A transmitter unit is coupled to the glucose sensor and processes data indicative of a plurality of monitored glucose levels from the glucose sensor. A receiver unit receives the processed data from the transmitter unit. The receiver unit comprises a processor and a user interface having a touch-sensitive display to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displaying the plurality of monitored glucose levels, a second panel simultaneously displaying a current glucose level and a glucose trend indicator, and a third panel displays status information of a plurality of components of the system. When an alarm condition is detected, the display renders the alert screen in place of one of the first panel, the second panel, or the third panel. The alert screen displays information corresponding to the detected alarm condition. The display affects a further output corresponding to the detected condition in response to user actuation of a portion of the display.

APPARATUS FOR MONITORING GLUCOSE AND METHOD THEREOF

Resumen de: EP4574039A1

An apparatus for monitoring glucose according to an embodiment of the present invention includes an input unit that obtains first biometric information including a plurality of data points measuring glucose-related information of a subject; a noise removal unit that removes noise information included in the first biometric information; a preprocessing unit that preprocesses the first biometric information from which the noise information is removed to generate second biometric information having a lower sampling rate than the first biometric information; a compensation unit that generates compensation data based on the second biometric information and generates a calibration algorithm based on the compensation data; and a glucose level acquisition unit that acquires a glucose level related to the second biometric information by reflecting the calibration algorithm and a set time delay.

METHOD AND COMPUTING DEVICE FOR NON-INVASIVELY ESTIMATING BLOOD GLUCOSE, DEVICE FOR NON-INVASIVELY MEASURING ELECTROCARDIOGRAM SIGNAL, AND NON-TRANSITORY COMPUTER READABLE STORAGE MEDIUM

Resumen de: EP4574023A1

A method for non-invasively estimating blood glucose for estimating a blood glucose value of a user by a computing device (400A, 400B, 2600). The method includes receiving a plurality of electrocardiogram (ECG) waveforms of the user, extracting at least two first ECG features from each of the plurality of ECG waveforms of the user, respectively determining a first feature peak position corresponding to each of the first ECG features, calculating at least one peak distance between the plurality of the first feature peak positions, and estimating the blood glucose value of the user based on the peak distance. The first ECG features are selected from the group consisting of a P-wave, a Q-wave, an R-wave, an S-wave, a T-wave, and a U-wave. Furthermore, a computing device (2600) for non-invasively estimating blood glucose, a device (2700) for non-invasively measuring ECG signal, and a non-transitory computer readable storage medium are utilized for the method.

DEVICE AND METHOD FOR DETERMINING A GLUCOSE CONCENTRATION

Nº publicación: EP4572667A1 25/06/2025

Solicitante:

TRUMPF PHOTONIC COMPONENTS GMBH [DE]
TRUMPF Photonic Components GmbH

Resumen de: US2025176870A1

A device for determining a glucose concentration in an anterior chamber of a user's eye includes a VCSEL which emits laser light, and an optical element for influencing the laser light and/or an emergent light. The VCSEL and the optical element are configured such that the laser light enters the anterior chamber of the eye. The emergent light from the anterior chamber penetrates into the VCSEL. The device further includes an analysis unit that analyses a resulting self-mixing interference within the VCSEL to determine the glucose concentration.